Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Year : 2022  |  Volume : 32  |  Issue : 3  |  Page : 168-171

Aortic biological prosthetic valve dysfunction secondary to endocarditis: Is percutaneous valve-in-valve an option?

Division of Cardiology, A.O.U. Policlinico “G. Rodolico - San Marco”, Catania, Italy

Correspondence Address:
Paolo Zappulla
Division of Cardiology, A.O.U. Policlinico “G. Rodolico - San Marco”, Via Santa Sofia N 78, Catania
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jcecho.jcecho_15_22

Rights and Permissions

We present the case of a 69-year-old man with an aortic biological prosthetic valve. In May 2019, the patient experienced increasing dyspnea and fatigue: A diagnosis of prosthetic aortic valve dysfunction was made, leading to severe valvular insufficiency. The dysfunction of the prosthetic valve seemed to be linked to a previous infective endocarditis: after ruling out active endocarditis, the patient was treated with an off-label valve-in-valve transcatheter aortic valve implantation.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded12    
    Comments [Add]    

Recommend this journal